Clinical Research Directory
Browse clinical research sites, groups, and studies.
Tapering of Inhaled Corticosteroids in Tezepelumab-treated Asthma patieNts: Impact on Clinical Outcomes: Inhaled Corticosteroids Will be Tapered According to Standard Care, in Severe Asthma Patients Which Have Started Treatment With Tezepelumab
Sponsor: Franciscus Gasthuis
Summary
To evaluate the relationship between starting tezepelumab treatment followed by tapering of inhaled corticosteroid (ICS) and ICS dose, metabolic outcomes, asthma control and exacerbation rate in a real world setting
Official title: TITANIC - Tapering of Inhaled Corticosteroids in Tezepelumab-treated Asthma patieNts: Impact on Clinical Outcomes
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
OBSERVATIONAL
Enrollment
61
Start Date
2026-05-01
Completion Date
2027-10
Last Updated
2026-07-20
Healthy Volunteers
No
Conditions
Interventions
Tapering of inhaled corticosteroid (ICS) treatment
All patients that have started tezepelumab treatment are eligible for tapering of ICS, since it is part of standard care.
Locations (1)
Franciscus Gasthuis & Vlietland
Rotterdam, South Holland, Netherlands